Multiple drug resistant tuberculosis: Centralized mycobacterial reference using molecular techniques can help

Journal of Antimicrobial Chemotherapy

Volumn 37, Issue 1, 1996, Pages 5-6

  Davies, P D O ^a  

^a LIVERPOOL HEART AND CHEST HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; RIFAMPICIN; TUBERCULOSTATIC AGENT;

EDITORIAL; MULTIDRUG RESISTANCE; TUBERCULOSIS;

DNA, BACTERIAL; HUMANS; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 0029886447     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/37.1.5     Document Type: Editorial

References (19)

1. Alland, D., Kalkut, G. E., Moss, A. R., McAdam, R. A., Hahn, J. A., Bosworth, W. et al. (1994). Transmission of tuberculosis in New York city - an analysis by DNA fingerprinting and conventional epidemiological methods. New England Journal of Medicine 330, 1710-6.
2. Aziz, A., Siddiqui, S. H & Ishaq, M. (1989). Drug resistance in Mycobacterium tuberculosis isolated in treated patients in Pakistan, Tubercle 70, 45-52.
3. Brisson-Noel, A., Gicquel, B., Locossier, D., Levy-Frebault, V., Nassif, X. & Hance, A. J. (1990). Rapid diagnosis of tuberculosis by amplification of mycobacterial DNA in clinical specimens. Lancet ii, 1069-71.
4. Davies, P. D. O. (1993). Tuberculosis is increasing in England and Wales. British Medical Journal 307, 63.
5. Davies, P. D. O. (1995). Tuberculosis and migration. Journal of the Royal College of Physicians of London 29, 113-8.
6. Dooley, S. W. & Simone, P. M. (1994). The extent and management of Drug-resistant tuberculosis: the American experience. In Clinical Tuberculosis (Davies, P. D. O., Ed.), pp. 172-89. Chapman and Hall, London.
7. Frieden, T. R., Sterling, T., Pablos-Mendez, A., Kilburn, J. O., Cauthen, G. M. & Dooley, S. W. (1993). The emergence of drug-resistant tuberculosis in New York City. New England Journal of Medicine 328, 521-7.
8. Iseman, M. (1993). Treatment of multi-drug-resistant tuberculosis. New England Journal of Medicine 329, 784-91.
9. Medical Research Council Tuberculosis and Chest Disease Unit. (1980). A national survey of tuberculosis notifications in England and Wales 1978-9. British Medical Journal 281, 895-8.
10. Medical Research Council Tuberculosis and Chest Diseases Unit. (1985). A national survey of notifications of tuberculosis in England and Wales 1983. British Medical Journal 291, 658-61.
11. Medical Research Council Cardiothoracic Epidemiology Group. (1992). National survey of notifications of tuberculosis in England and Wales in 1988. Thorax 47, 770-5
12. Otal, I., Martin, C., Levy-Frebault, V., Thierry, D. & Gicquel, B. (1991). Restriction fragment length polymorphism analysis using IS6110 as an epidemiological marker in tuberculosis. Journal of Clinical Microbiology 29, 1252-4.
13. Small, P. M., Hopewell, P. C., Singh, S. P., Paz, A., Parsonnet, J., Ruston, D. C. et al. (1994). The spidemiology of tuberculosis in San Francisco - a population based study using conventional and molecular methods. New England Journal of Medicine 330, 1703-9.
14. Snider, D. E., Cauthen, G. M., Farer, L. S., Kelly G. D., Kilburn, J O., Good, R. C. et al. (1991). Drug resistant tuberculosis. American Review of Respiratory Diseases 144, 732.
15. Stoker, N. (1994). Tuberculosis in a changing world - don't stint on the surveillance and control. British Medical Journal 309, 1178-9.
16. Tahaoglu, K., Kizkin, O., Karagoz, T., Tor, M., Partal, M. & Sadoglu T. (1994). High initial and acquired drug resistance in pulmonary tuberculosis. Tubercle and Lung Disease 75, 324-8.
17. Trivedy, S. S. & Desai, S.G. (1988). Primary antituberculosis drug resistance and acquired rifampicin resistance in Gujarat. India. Tubercle 69, 37-42.
18. Warburton, A. R E., Jenkins, P. A., Wright, P. A. & Watson, J. M. (1993). Drug resistance in initial isolates of M. tuberculosis in England and Wales, 1987-91. Communicable Diseases Report 3:R175-9.
19. Weltman, A C. & Rose, D. N. (1994). Tuberculosis susceptibility patterns, predictors of multidrug resistance, and implications for initial therapeutic regimens at a New York city hospital. Archives of Internal Medicine 154, 2161-7.